Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen.
Journal
The New England journal of medicine
ISSN: 1533-4406
Titre abrégé: N Engl J Med
Pays: United States
ID NLM: 0255562
Informations de publication
Date de publication:
25 Jan 2024
25 Jan 2024
Historique:
medline:
24
1
2024
pubmed:
24
1
2024
entrez:
24
1
2024
Statut:
ppublish
Résumé
The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with ibuprofen would improve short-term outcomes is not known. We conducted a multicenter, randomized, double-blind, placebo-controlled trial evaluating early treatment (≤72 hours after birth) with ibuprofen for a large PDA (diameter of ≥1.5 mm with pulsatile flow) in extremely preterm infants (born between 23 weeks 0 days' and 28 weeks 6 days' gestation). The primary outcome was a composite of death or moderate or severe bronchopulmonary dysplasia evaluated at 36 weeks of postmenstrual age. A total of 326 infants were assigned to receive ibuprofen and 327 to receive placebo; 324 and 322, respectively, had data available for outcome analyses. A primary-outcome event occurred in 220 of 318 infants (69.2%) in the ibuprofen group and 202 of 318 infants (63.5%) in the placebo group (adjusted risk ratio, 1.09; 95% confidence interval [CI], 0.98 to 1.20; P = 0.10). A total of 44 of 323 infants (13.6%) in the ibuprofen group and 33 of 321 infants (10.3%) in the placebo group died (adjusted risk ratio, 1.32; 95% CI, 0.92 to 1.90). Among the infants who survived to 36 weeks of postmenstrual age, moderate or severe bronchopulmonary dysplasia occurred in 176 of 274 (64.2%) in the ibuprofen group and 169 of 285 (59.3%) in the placebo group (adjusted risk ratio, 1.09; 95% CI, 0.96 to 1.23). Two unforeseeable serious adverse events occurred that were possibly related to ibuprofen. The risk of death or moderate or severe bronchopulmonary dysplasia at 36 weeks of postmenstrual age was not significantly lower among infants who received early treatment with ibuprofen than among those who received placebo. (Funded by the National Institute for Health Research Health Technology Assessment Programme; Baby-OSCAR ISRCTN Registry number, ISRCTN84264977.).
Sections du résumé
BACKGROUND
BACKGROUND
The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with ibuprofen would improve short-term outcomes is not known.
METHODS
METHODS
We conducted a multicenter, randomized, double-blind, placebo-controlled trial evaluating early treatment (≤72 hours after birth) with ibuprofen for a large PDA (diameter of ≥1.5 mm with pulsatile flow) in extremely preterm infants (born between 23 weeks 0 days' and 28 weeks 6 days' gestation). The primary outcome was a composite of death or moderate or severe bronchopulmonary dysplasia evaluated at 36 weeks of postmenstrual age.
RESULTS
RESULTS
A total of 326 infants were assigned to receive ibuprofen and 327 to receive placebo; 324 and 322, respectively, had data available for outcome analyses. A primary-outcome event occurred in 220 of 318 infants (69.2%) in the ibuprofen group and 202 of 318 infants (63.5%) in the placebo group (adjusted risk ratio, 1.09; 95% confidence interval [CI], 0.98 to 1.20; P = 0.10). A total of 44 of 323 infants (13.6%) in the ibuprofen group and 33 of 321 infants (10.3%) in the placebo group died (adjusted risk ratio, 1.32; 95% CI, 0.92 to 1.90). Among the infants who survived to 36 weeks of postmenstrual age, moderate or severe bronchopulmonary dysplasia occurred in 176 of 274 (64.2%) in the ibuprofen group and 169 of 285 (59.3%) in the placebo group (adjusted risk ratio, 1.09; 95% CI, 0.96 to 1.23). Two unforeseeable serious adverse events occurred that were possibly related to ibuprofen.
CONCLUSIONS
CONCLUSIONS
The risk of death or moderate or severe bronchopulmonary dysplasia at 36 weeks of postmenstrual age was not significantly lower among infants who received early treatment with ibuprofen than among those who received placebo. (Funded by the National Institute for Health Research Health Technology Assessment Programme; Baby-OSCAR ISRCTN Registry number, ISRCTN84264977.).
Identifiants
pubmed: 38265644
doi: 10.1056/NEJMoa2305582
doi:
Banques de données
ISRCTN
['ISRCTN84264977']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
314-325Subventions
Organisme : Health Technology Assessment Programme
ID : HTA Project: 11/92/15
Investigateurs
Saulius Satas
(S)
Margaret Connon
(M)
Stephen Main
(S)
Susan MacFarlane
(S)
Anthony Wilfred Ross Kelsall
(AW)
Katherine Bradly Russell
(K)
Helen Shelley
(H)
Beth Berthlecon
(B)
Sajeev Job
(S)
Anand Kamalanathan
(A)
Sharon Hughes
(S)
Lucy Lewis
(L)
Aung Soe
(A)
Jaideep Singh
(J)
Eve Irvine
(E)
Katie Price
(K)
Laura Thrasyvoulou
(L)
Juneka Begum
(J)
Jacqueline Daglish
(J)
Vishna Rasiah
(V)
Anju Singh
(A)
Rachel Jackson
(R)
Efygenia Kotsia
(E)
Amy Woodhead
(A)
Abby Twiss
(A)
Maxine Heather Barrow
(MH)
Elizabeth Simcox
(E)
Sam Wallis
(S)
Rachel Wane
(R)
Savithiri Sivashankar
(S)
Emily Andrews
(E)
Heather Collier
(H)
Chi-Ning Gerrard
(CN)
Caroline Cowman
(C)
Bev Hammond
(B)
Frances Pickering
(F)
Robert John Madar
(RJ)
Sarah-Jane Sharman
(SJ)
Alison Stolton
(A)
Jonathan Wyllie
(J)
Caroline Buckley
(C)
Amanda Forster
(A)
Helena Smith
(H)
Suzanne Bell
(S)
Porus Bustani
(P)
Pauline Bayliss
(P)
Rachel Sellars
(R)
Lynne Smart
(L)
Liz Taylor
(L)
Beth Lally
(B)
Lawrence Miall
(L)
Nicola Balatoni
(N)
Suzanne Laing
(S)
Collette Spencer
(C)
Sarah Thornton
(S)
Lindsay Uryn
(L)
Laura Dalton
(L)
Katherine Pettinger
(K)
Charlotte Reilly
(C)
Jonathan Cusack
(J)
Marie Hubbard
(M)
Rosalind Astles
(R)
Maria Sharpe
(M)
Jennifer Smith
(J)
Nimish Subhedar
(N)
Karen Harvey
(K)
Joanne Windrow
(J)
Patrick McGowan
(P)
Amy Beasley
(A)
Sateeshkumar Somisetty
(S)
Yvonne Millar
(Y)
Olaitan Adesiyan
(O)
Jenny Baker
(J)
Santosh Pattnayak
(S)
Helen Harizaj
(H)
Aimee Harris
(A)
Sarah Jones
(S)
Alison Youdale
(A)
Rahul Roy
(R)
Samantha Claire
(S)
Supriya Bhoomaiah
(S)
Karen Few
(K)
Katherine Lloyd
(K)
Amy Nichols
(A)
Laura Playne
(L)
Jay Banerjee
(J)
Batia Gourin
(B)
Zoe McClure
(Z)
Kirupalini Mariampillai
(K)
Sundar Satyamurthy
(S)
Christopher Kissack
(C)
Sally Yip
(S)
Lynn Clark
(L)
Bharathi Rao
(B)
Eileen Killen
(E)
Jennifer McGowan
(J)
Muriel Millar
(M)
Mary O'Neill
(M)
Angela Abbate
(A)
Rachel Anderson
(R)
Julie Brown
(J)
Patrick Lawlor
(P)
Judith Ratcliffe
(J)
Eileen Rogers
(E)
Akaolisa Egbeama
(A)
Joanna Lees
(J)
Claire Lodge
(C)
Natalie Morgan
(N)
Raju Narasimhan
(R)
Paula Sugden
(P)
Sundeep Harigopal
(S)
Julie Groombridge
(J)
Tracey Downes
(T)
Donovan Duffy
(D)
Naomi Hayward
(N)
Anay Kulkarni
(A)
Izabela Andrzejewska
(I)
Vania Oliveira
(V)
Sundar Sathiyamurthy
(S)
Arindam Mukherjee
(A)
Nicola Booth
(N)
Karen Dockery
(K)
Clare Jennings
(C)
Louise Weaver-Lowe
(L)
Katherine Birchall
(K)
Majid Abu-Harb
(M)
Natalie Talbot
(N)
Paul Corrigan
(P)
Siddhartha Sen
(S)
Alison Davies
(A)
Angela Harris
(A)
Ajay Sinha
(A)
MaySze Chang
(M)
Caroline Francia
(C)
Ivone Lancoma-Malcolm
(I)
Gail Falder
(G)
Rainer Ebel
(R)
Mrinalini Rajimwale
(M)
Francesca Brewer
(F)
Rebecca Grenfell
(R)
Nicola Watts
(N)
Laura Wild
(L)
Nicolas Aldridge
(N)
Susan Dale
(S)
Jo Gmerek
(J)
Kerri McGowan
(K)
Samir Gupta
(S)
Sundaram Janakiraman
(S)
Alex Ramshaw
(A)
Wendy Cheadle
(W)
Chidambara Harikumar
(C)
Nazakat Merchant
(N)
Shabana Malik
(S)
Suminthra Naidu
(S)
Rona Verdadero
(R)
Amit Gupta
(A)
Shermi George
(S)
Claire Moloney
(C)
Vimal Vasu
(V)
Gopala Krishnan
(G)
Denise Vigni
(D)
Jennifer Bell
(J)
Ursula Bowler
(U)
Christina Cole
(C)
Kerrianne Dempster
(K)
Clare Edwards
(C)
Pollyanna Hardy
(P)
Nina Jamieson
(N)
Edmund Juszczak
(E)
Ann Kennedy
(A)
Andy King
(A)
Marketa Laube
(M)
Louise Linsell
(L)
David Murray
(D)
Heather O'Connor
(H)
Charles Roehr
(C)
Kayleigh Stanbury
(K)
Julia Sutton
(J)
Joy Wiles
(J)
Tracey Roberts
(T)
Chidubem Okeke Ogwulu
(CO)
Jane Greenaway
(J)
Pauline Shephard
(P)
Volker Straub
(V)
Justin Carter
(J)
Ben Snook
(B)
Denis Azzopardi
(D)
Michael Weindling
(M)
Narender Aladangady
(N)
Sophie Welch
(S)
Tim Clayton
(T)
Alan Montgomery
(A)
David Edwards
(D)
Heike Rabe
(H)
Informations de copyright
Copyright © 2024 Massachusetts Medical Society.